safinamide has been researched along with escitalopram in 1 studies
| Studies (safinamide) | Trials (safinamide) | Recent Studies (post-2010) (safinamide) | Studies (escitalopram) | Trials (escitalopram) | Recent Studies (post-2010) (escitalopram) |
|---|---|---|---|---|---|
| 199 | 29 | 159 | 221 | 55 | 208 |
| Protein | Taxonomy | safinamide (IC50) | escitalopram (IC50) |
|---|---|---|---|
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.5374 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blicharz, K; Bojarski, AJ; Doroz-Płonka, A; Grychowska, K; Jastrzębska-Więsek, M; Karcz, T; Keeri, AR; Koczurkiewicz, P; Krawczyk, M; Kurczab, R; Lamaty, F; Latacz, G; Malikowska-Racia, N; Olejarz-Maciej, A; Partyka, A; Pęgiel, J; Pietruś, W; Piska, K; Popik, P; Satała, G; Trybała, W; Walczak, M; Zajdel, P | 1 |
1 other study(ies) available for safinamide and escitalopram
| Article | Year |
|---|---|
Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines.
Topics: Animals; Brain; Fluorine; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quinolines; Rats | 2022 |